SCHEMBL8808399

SCHEMBL8808399

Cc1oncc1C(=O)N(Cc1ccccc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
GMNN O75496 1/20 0.51
LMNA P02545 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
HTR1A P08908 1/20 0.51
THRB P10828 1/20 0.51
PIM1 P11309 1/20 0.51
CYP2C9 P11712 1/20 0.51
MAOA P21397 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR2A P28223 1/20 0.51
AGTR1 P30556 1/20 0.51
CCKBR P32239 1/20 0.51
MC4R P32245 1/20 0.51
CYP2C19 P33261 1/20 0.51
THPO P40225 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9754181 0.90 NR1H4 (0.43) RAB9ANPC1GMNNLMNATP53
SCHEMBL3049960 0.88 PDK1 (0.52) RAB9ANPC1HTTSMN1; SMN2PDK2
SCHEMBL9754183 0.88 PDK1 (0.43) RAB9APDK2PDK4PDK1ATF1
SCHEMBL5071947 0.83 NPC1 (0.55) RAB9ANPC1GMNNLMNATP53
SCHEMBL9539254 0.83 RAB9A (0.50) RAB9ANPC1HTTPDK2PDK4
SCHEMBL3059654 0.82 GAA (0.50) PDK2PDK4PDK1ATF1NFKB1
SCHEMBL27323811 0.80 LMNA (0.41) RAB9ANPC1GMNNLMNATP53
SCHEMBL8811883 0.79 SMN1; SMN2 (0.59) RAB9ANPC1GMNNLMNATP53
SCHEMBL4661455 0.77 GAA (0.50) RAB9APDK2PDK4PDK1ATF1
SCHEMBL3065041 0.76 TSHR (0.56) NPC1PDK2PDK4PDK1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527736-B1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AG (DE) 1997-04-16 EP disclosed
US-5532259-A ANTITUMOR HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-02 US disclosed
US-5494911-A TREATING LEUKEMIA, SARCOMA, CARCINOMA, LYMPHOMA, SKIN CANCER HOECHST AKTIENGESELLSCHAFT (DE) 1996-02-27 US disclosed